Apologies, slight correction, the example used wasn't Clinuvel, it was Opthea which is also an ASX listed co.
They are the ones with the Wet Macular therapy. The example still stands, a funding pathway that could work.
- Forums
- ASX - By Stock
- PAR
- The Funding Paradigm.
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.82%
!
34.5¢

The Funding Paradigm., page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $141.0M |
Open | High | Low | Value | Volume |
36.0¢ | 36.0¢ | 34.5¢ | $42.25K | 120.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 109506 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 24790 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11858 | 0.345 |
9 | 105057 | 0.340 |
2 | 11414 | 0.335 |
6 | 78171 | 0.330 |
3 | 40868 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 24790 | 2 |
0.355 | 8698 | 4 |
0.360 | 29212 | 5 |
0.365 | 25903 | 7 |
0.370 | 25661 | 3 |
Last trade - 10.13am 01/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |